Palliative care and end-of-life planning in Parkinson’s disease

被引:0
作者
Richard William Walker
机构
[1] Northumbria Healthcare NHS Foundation Trust,
[2] North Tyneside General Hospital,undefined
来源
Journal of Neural Transmission | 2013年 / 120卷
关键词
Parkinson’s disease; Palliative care; End-of-life; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
In Parkinson’s disease (PD) typical “palliative care” type symptoms, such as pain, nausea, weight loss and breathlessness can occur throughout the condition, but become more prevalent in later disease stages. Pain may be specifically related to PD, e.g. dystonic pain with wearing off, but is more commonly due to other conditions. The cause can usually be elicited by a careful history and examination, and this guides intervention, both non-pharmaceutical, and pharmaceutical. For example, dystonic pain will respond best to appropriate changes to dopaminergic medication. In later disease stages people have increasing problems with swallowing, and also cognitive impairment. Impaired swallowing may lead to aspiration pneumonia, which is a common cause of hospital admission, and also death. Decisions about interventions towards the end of life, such as insertion of percutaneous endoscopic gastrostomy (PEG) tube for nutrition, can be very challenging, particularly if, as in most cases, the person with PD has not previously expressed their views upon this while they still maintained capacity to make decisions. Advance care planning (ACP) in PD should be encouraged in relation to interventions such as PEG tubes. It may also cover issues such as preferred place of death. Over recent years lower proportions of people have been dying at home, and this is especially true for PD, but home may well be where they would have preferred to die. However, there is little evidence to guide health professionals about how, when, and by whom, ACP should be approached.
引用
收藏
页码:635 / 638
页数:3
相关论文
共 84 条
[1]  
Barnes K(2007)Acceptability of an advance care planning interview schedule: a focus group study Palliat Med 21 23-28
[2]  
Jones L(1989)Physician’s attitudes on advance directives J Am Med Assoc 262 2415-2419
[3]  
Tookman A(1989)Preferred versus actual place of death: a hospital palliative care support team experience Palliat Med 3 197-201
[4]  
King M(1991)Advance directives for medical care—a case for greater use N Engl J Med 324 889-895
[5]  
Davidson KW(2006)Effects of a program for coordinated care of advanced illness on patients, surrogates and healthcare costs: a randomized trial Am J Manag Care 12 93-100
[6]  
Hackler C(1994)Which patients with terminal cancer are admitted from homecare? Palliat Med 8 197-210
[7]  
Caradine DR(2006)Advance care planning for patients with inoperable lung cancer Int J Palliat Nurs 12 172-178
[8]  
McCord RS(2000)Paradoxes in cancer patients’ advance care planning J Palliat Med 3 27-35
[9]  
Dunlop RJ(2007)Advance directives: results of a community education symposium Crit Care Nurse 27 31-35
[10]  
Davies RJ(2006)A survey of pain in idiopathic Parkinson’s disease J Pain Symptom Manag 32 462-469